Company Performance Metrics
- Carl Hansen: CEO
- Véronique Lecault: Co-Founder
AbCellera is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic – and patients – sooner.
With the integrated AbCellera platform, our experts search a wide range of diverse
antibodies to select the most effective and developable leads fast and set our partners up for enduring success.
We have extensive experience forging partnerships with emerging biotechs and leading pharmaceutical companies. AbCellera leverages proprietary hardware, software, tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
